FinTech Health Care Disruptor Lane Health Taps Christopher Aguwa as Chief Commercial Officer

Health care industry veteran Christopher Aguwa selected as Chief Commercial Officer for Lane Health NEW YORK, Sept. 18, 2023 /PRNewswire/ — Lane Health, a leading health care disruptor that infuses fintech into the challenging world of health care, today announced health care industry veteran Christopher Aguwa as its Chief Commercial Officer. In his new role, Aguwa will … Read more

Versiti Blood Center of Michigan Issues Emergency Appeal for Blood Donations

State’s blood supply is at a dangerously low point, putting patients at risk GRAND RAPIDS, Mich., Sept. 17, 2023 /PRNewswire/ — Versiti Blood Center of Michigan has issued an emergency appeal for blood donations, pleading with community members to make an appointment to donate blood in the coming days. Heading into the fall, Versiti has seen … Read more

One-Day Strike Notice Issued by MNA Nurses at Dana-Farber Cancer Institute

Nurses are planning a one-day strike for September 27 because Dana-Farber is undermining the stability of its nursing workforce in Merrimack Valley and putting patient care quality at risk by not settling a fair contract METHUEN, Mass., Sept. 16, 2023 /PRNewswire/ –The registered nurses of Dana-Farber Cancer Institute – Merrimack Valley, represented by the Massachusetts … Read more

Global Vacuum Ovens Market Flourishes with Expected Valuation of $343.2 Million by 2028; Robust CAGR of 6.38% Foreseen

DUBLIN, Sept. 15, 2023 /PRNewswire/ — The “Vacuum Ovens Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global vacuum ovens market exhibited strong growth in 2022, reaching a total valuation of US$ 234.3 million. According to this report the market is poised for continued expansion, … Read more

MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study

GENEVA, Sept. 15, 2023 /PRNewswire/ — MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel sirolimus drug-eluting balloon (SELUTION SLR), versus any limus drug-eluting stent (DES). MedAlliance Announces Enrollment … Read more

CEO has purchased shares in Vitrolife AB

GOTHENBURG, Sweden, Sept. 14, 2023 /PRNewswire/ — Bronwyn Brophy O´Connor, CEO Vitrolife AB, has acquired 19,350 shares worth 2,495,957 SEK. The total holdings of shares amount to 19,350. The transaction will be reported to The Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations. “I am delighted to invest in the Vitrolife Group as I … Read more

September Is National PACE Month

ALEXANDRIA, Va., Sept. 13, 2023 /PRNewswire/ — The National PACE Association (NPA) has announced this year’s theme for National PACE Month in September: “PACE: Where You Belong.” The theme celebrates the ways that the PACE model of care builds and strengthens connections between enrollees, PACE caregivers and family. National PACE Month celebrates the Program of … Read more

Tissue Engineering and Regeneration Market to grow by USD 21.27 billion from 2022 to 2027, North America to account for 47% of market growth- Technavio

NEW YORK, Sept. 12, 2023 /PRNewswire/ — The tissue engineering and regeneration market is expected to grow by USD 21.27 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 14.93% during the forecast period, according to Technavio Research. The market is segmented by material (synthetic, biologic, and genetically modified), application … Read more

Foresee Pharmaceuticals Presents Data From its Aderamastat Program at The European Respiratory Society (ERS) International Congress 2023

Late-breaking oral presentation on the positive primary outcomes of aderamastat, a first-in-class, oral MMP-12 inhibitor in a Phase 2 Phase 2 proof-of-concept allergic asthma study, supporting potential novel anti-inflammatory mechanism for respiratory diseases. TAIPEI, Sept. 12, 2023 /PRNewswire/ — Foresee Pharmaceuticals (TPEx: 6576), (“Foresee”) announced today that the company presented the positive primary outcomes of … Read more

La nouvelle déclaration de Samarkand en faveur des droits des femmes et des petites exploitations agricoles est annoncée lors de la Conférence internationale sur la sécurité alimentaire en Ouzbékistan USA – Français USA – English Middle East – Arabic

Des accords d’une valeur de 1,88 milliard de dollars américains ont été signés lors du Forum sur l’investissement agroalimentaire SAMARKAND, Ouzbékistan, 11 septembre 2023 /PRNewswire/ — Un nouvel accord définissant les principales priorités de la coopération internationale en matière de sécurité alimentaire a été annoncé lors de la Conférence internationale sur la sécurité alimentaire (jeudi … Read more